PAHC - Phibro Animal Health Corporation
32.41 0.00 (0.00%)
After hours: 5:00PM EST
| Previous Close | 31.78 |
| Open | 31.79 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 31.79 - 32.60 |
| 52 Week Range | 30.79 - 54.62 |
| Volume | 73,416 |
| Avg. Volume | 125,864 |
| Market Cap | 1.309B |
| Beta (3Y Monthly) | -0.05 |
| PE Ratio (TTM) | 20.01 |
| EPS (TTM) | 1.62 |
| Earnings Date | Feb 6, 2019 |
| Forward Dividend & Yield | 0.48 (1.44%) |
| Ex-Dividend Date | 2018-11-27 |
| 1y Target Est | 35.33 |
- Markit•2 days ago
See what the IHS Markit Score report has to say about Phibro Animal Health Corp.
# Phibro Animal Health Corp ### NASDAQ NMS:PAHC View full report here! ## Summary * Bearish sentiment is low * Economic output in this company's sector is expanding ## Bearish sentiment Short interest | Positive Short interest is extremely low for PAHC with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PAHC. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $1.46 billion over the last one-month into ETFs that hold PAHC are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Positive According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- GlobeNewswire•14 days ago
Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2018 Quarterly Financial Results
TEANECK, N.J., Jan. 02, 2019 -- Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 6, 2019, after.
- Simply Wall St.•22 days ago
Should You Be Tempted To Sell Phibro Animal Health Corporation (NASDAQ:PAHC) Because Of Its P/E Ratio?
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll look at Phibro Animal Health Corporation's (NASDAQ:PAHC) P/E ratio and reflect Read More...
- Business Wire•27 days ago
Phibro Animal Health Works with Dr. Lon Whitlow on Preventing, Recognizing and Mitigating Mycotoxin Contamination
It is not a riddle — it’s mycotoxins, which dairy producers must contend with on a regular basis. Fortunately, the more you know about mycotoxins, the easier they are to prevent, recognize and mitigate. Unfortunately, mycotoxins routinely occur in feeds.
- Insider Monkey•last month
Hedge Funds Are Crazy About Phibro Animal Health Corp (PAHC)
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed heavily on the minds of investors. Both the S&P 500 and Russell 2000 sank as a result, with the Russell 2000, […]
Zacks•last monthMoving Average Crossover Alert: Phibro Animal Health Corporation
Phibro Animal Health Corporation could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Markit•last monthSee what the IHS Markit Score report has to say about Phibro Animal Health Corp.
Phibro Animal Health Corp NASDAQ NMS:PAHC
- GlobeNewswire•last month
Aquaculture Acquisition to Create Vaccine Innovation Powerhouse
Phibro Animal Health Corporation (PAHC) today announced it has acquired the assets of KoVax Ltd., an Israel-based developer and manufacturer of vaccines for the global aquaculture market. The acquisition strengthens Phibro’s position in fish vaccine innovation and expands its portfolio of aquaculture products. Phibro’s first commercial aquaculture vaccine is KoVax’s “KV3” vaccine, which helps prevent Koi Herpes Virus, a highly contagious disease that can cause significant mortality in common carp farms.
- Zacks•last month
Phibro (PAHC) Down 14.8% Since Last Earnings Report: Can It Rebound?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire•2 months ago
New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Nov. 27, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Zacks•2 months ago
Moving Average Crossover Alert: Phibro Animal Health (PAHC)
Phibro Animal Health (PAHC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Markit•2 months agoSee what the IHS Markit Score report has to say about Phibro Animal Health Corp.
Phibro Animal Health Corp NASDAQ NMS:PAHC
- Simply Wall St.•2 months ago
Should You Worry About Phibro Animal Health Corporation’s (NASDAQ:PAHC) CEO Pay?
Jack Bendheim became the CEO of Phibro Animal Health Corporation (NASDAQ:PAHC) in 2014. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will Read More...
Markit•2 months agoSee what the IHS Markit Score report has to say about Phibro Animal Health Corp.
Phibro Animal Health Corp NASDAQ NMS:PAHC
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of PAHC earnings conference call or presentation 7-Nov-18 2:00pm GMT
Q1 2019 Phibro Animal Health Corp Earnings Call
- Zacks•2 months ago
Phibro Animal (PAHC) Q1 Earnings Lag Estimates, Sales Up Y/Y
Within Animal Health business of Phirbo Animal (PAHC), reduced selling prices across certain countries partially offset its international volume growth.
Motley Fool•2 months agoPhibro Animal Health Corp (PAHC) Q1 2019 Earnings Conference Call Transcript
PAHC earnings call for the period ending September 30, 2018.
- Associated Press•2 months ago
Phibro: Fiscal 1Q Earnings Snapshot
The Teaneck, New Jersey-based company said it had net income of 40 cents per share. Earnings, adjusted for non-recurring gains, were 39 cents per share. The maker of animal health products and nutritional ...
- GlobeNewswire•2 months ago
Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J., Nov. 05, 2018 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its.
- Simply Wall St.•3 months ago
Is Phibro Animal Health Corporation (NASDAQ:PAHC) A High Quality Stock To Own?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
Markit•3 months agoSee what the IHS Markit Score report has to say about Phibro Animal Health Corp.
Short interest is extremely low for PAHC with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PAHC. The net inflows of $3.78 billion over the last one-month into ETFs that hold PAHC are not among the highest of the last year and have been slowing.
